β1-Adrenergic receptors mediate β3-adrenergic-independent effects of CGP 12177 in brown adipose tissue

Molecular Pharmacology

Volumn 57, Issue 2, 2000, Pages 252-258

  Konkar, Anish A ^a   Zhai, Ying ^a   Granneman, James G ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADENYLATE CYCLASE; BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; ISOPRENALINE; LIGAND; PROPRANOLOL; RECEPTOR SUBTYPE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; PROPANOLAMINE DERIVATIVE; RECOMBINANT PROTEIN;

ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; BROWN ADIPOSE TISSUE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; DBA MOUSE; DRUG EFFECT; FEMALE; HAMSTER; HUMAN; MALE; METABOLISM; MOUSE; RAT;

ADENYLATE CYCLASE; ADIPOSE TISSUE, BROWN; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CHO CELLS; CRICETINAE; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; PROPANOLAMINES; RATS; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-3; RECOMBINANT PROTEINS;

EID: 0033621737     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Arch JR and Wilson S (1996) Prospects for β3-adrenoceptor agonists in the treatment of obesity and diabetes. Int J Obes Relat Metab Disord 20:191-199.
2. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
3. Bousquet-Mélou A, Galitzky J, Lafontan M and Berlan M (1995) Control of lipolysis in intra-abdominal fat cells of nonhuman primates: Comparison with humans. J Lipid Res 36:451-461.
4. Chaudhry A and Granneman JG (1991) Developmental changes in adenylyl cyclase and GTP binding proteins in brown fat. Am J Physiol 261:R403-R411.
5. Chaudhry A and Granneman JG (1994) Influence of cell type upon the desensitization of the β3-adrenergic receptor. J Pharmacol Exp Ther 271:1253-1258.
6. 3 adrenergic receptors to brown fat adenylyl cyclase. J Pharmacol Exp Ther 261:633-637.
7. 3-adrenoceptors in human brown and white adipose tissues. Br J Pharmacol 118:929-934.
8. 3-adrenoceptor in man. J Clin Invest 95:2239-2245.
9. Gaddum JH (1937) The quantitative effects of antagonist drugs. J Physiol (Lond) 89:7P-9P.
10. 4-adrenoceptor. Br J Pharmacol 122:1244-1250.
11. Gether U and Kobilka BK (1998) G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem 273;17979-17982.
12. Granneman JG (1990) Norepinephrine and BRL 37344 stimulate adenylate cyclase by different receptors in rat brown adipose tissue. J Pharmacol Exp Ther 254: 508-513.
13. 3-adrenergic receptor? Cell Signal 7:9-15
14. 3-adrenergic receptor. Mol Pharmacol 40:885-899.
15. 3-adrenergic receptor gene. Mol Pharmacol 44:264-270.
16. Granneman JG, Lahners KN and Zhai Y (1998) Agonist interactions with chimeric and mutant β1- and β3-adrenergic receptors: Involvement of the seventh transmembrane region in conferring subtype selectivity. Mol Pharmacol 53:856-861.
17. Granneman JG and Whitty C (1991) CGP 12177A modulates brown fat adenylate cyclase activity by interacting with two distinct receptor sites. J Pharmacol Exp Ther 256:421-425.
18. 3-adrenoceptor agonists on lipolysis in human omental adipocytes. Int J Obes 20:428-434.
19. Ito M, Grujic D, Abel ED, Vidal-Puig A, Susulic VS, Lawitts J, Harper ME, Himms-Hagen J, Strosberg AD and Lowell BB (1998) Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes 47:1464-1471.
20. 3-adrenoceptor in the rat. Br J Pharmacol 118:2085-2098.
21. Kaumann AJ and Molenaar P (1997) Modulation of human cardiac function through 4 β-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol 355:667-681.
22. Kaumann AJ, Preitner F, Sarsero D, Molenaar P, Revelli JP and Giacobino JP (1998) (-)-CGP 12177 causes cardiostimulation and binds to cardiac putative β4-adrenoceptors in both wild-type and β3-adrenoceptor knockout mice. Mol Pharmacol 53:670-675.
23. Kenakin TP (1982) The Schild regression in the process of receptor classification. Can J Physiol Pharmacol 60:249-265.
24. Kenakin TP, Bond RA and Bonner TI (1992) II. Definition of pharmacological receptors. Pharmacol Rev 44:351-362.
25. 3-adrenoceptor in man. Br J Pharmacol 110:929-936.
26. 3H]CGP-12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue. Biochem J 261:401-405.
27. 4-adrenoceptor' in mammalian heart. Clin Exp Pharmacol Physiol 24:647-656.
28. 1-adrenergic receptors. J Recept Signal Transduct Res 16:1-23.
29. Preitner F, Muzzin P, Revelli JP, Seydoux J, Galitzky J, Berlan M, Lafontan M and Giacobino JP (1998) Metabolic response to various beta-adrenoceptor agonists in beta3-adrenoceptor knockout mice: Evidence for a new beta-adrenergic receptor in brown adipose tissue. Br J Pharmacol 124:1684-1688
30. Rohrer DK, Desai KH, Jasper JR, Stevens ME, Regula DP Jr, Barsh GS, Bernstein D and Kobilka BK (1996) Targeted disruption of the mouse β1-adrenergic receptor gene: Developmental and cardiovascular effects. Proc Natl Acad Sci USA 93:7375-7380.
31. Salomon Y (1979) Adenylate cyclase assay. Adv Cyclic Nucleotide Res 10:35-55.
32. 3-adrenoceptor agonists of differing selectivities. J Pharmacol Exp Ther 285: 1084-1095.
33. Staehelin M, Simons P, Jaeggi K and Wigger N (1983) CGP-12177 a hydrophilic β-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem 258:3496-3502.
34. Susulic VS, Frederich RC, Lawitts J, Tozzo E, Kahn BB, Harper ME, Himms-Hagen J, Flier JS and Lowell BB (1995) Targeted disruption of the β3-adrenergic receptor gene. J Biol Chem 270:29483-29492.
35. Tavernier G, Barbe P, Galitzky J, Berlan M, Caput D, Lafontan M and Langin D (1996) Expression of β3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J Lipid Res 37:87-97.
36. 3-adrenoceptor agonist, on lipolysis of human and rat adipocytes. Harm Metab Res 28:394-396.